Back to results
US 8,481,713 B2Granted
Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives
AssigneeGilead Pharmasset LLC
InventorsPeiyuan Wang, Wojciech Stec, Byoung Kwon Chun, Junxing Shi, Jinfa Du
Life of this patent
Estimating the term…
Abstract
The present invention provides (i) a process for preparing a 2-deoxy-2-fluoro-2-methyl-D-ribonolactone derivative, (ii) conversion of the lactone to nucleosides with potent anti-HCV activity, and their analogues, and (iii) a method to prepare the anti-HCV nucleosides containing the 2-deoxy-2-fluoro-2-C-methyl-β-D-ribofuranosyl nucleosides from a preformed, preferably naturally-occurring, nucleoside.
Claims4
A method for the preparation of a 2′-deoxy-2′-fluoro-2′-C-methyl-β-D-ribofuranosyl nucleoside of the following formula:
- wherein the base is:
- wherein R2 and R4 are independently H, OH, NH2, or OR′;
- R′ is an optionally substituted straight, branched, or cyclic alkyl of C1-C12;
- Y is N or CH;
- the method comprising the following steps:
- (a) reacting a nucleoside intermediate of the following formula:
- wherein the protected base is the base protected by a protecting group, wherein the protecting group is benzoyl;
- wherein R3 and R5 are each independently tetrahydropyranyl, methyl, ethyl, benzyl, p-methoxybenzyl, benzyloxymethyl, phenoxymethyl, methoxymethyl, ethoxymethyl, mesyl, tosyl, trifluoroacetyl, or trichloroacetyl,
- with diethylaminosulfur trifluoride or bis(2-methoxyethyl)aminosulfur trifluoride to yield a fluorinated intermediate of the following formula:
- (b) deprotecting the R3 and R5 groups of the product of step (a) by treatment with a boron trihalide to yield an intermediate of the following formula:
- (c) saponifying the product of step (b) to yield the desired nucleoside.
8 more elements
Dependencies are inferred from the claim text.